Vermilionectomy for Actinic Cheilitis Treatment—Report of 03 Cases and Brief Literature Review
Case Reports in Dentistry · 2026-01 · 2026 (1)
DOI: 10.1155/crid/9721944 ↗Kurz gefasst
Fachartikel in der Zeitschrift Case Reports in Dentistry, online erschienen am 21.05.2026. Verfasst von Bruno Teixeira Gonçalves Rodrigues und 9 weiteren Autor:innen. Beteiligte Einrichtung: Oral and Maxillofacial Surgery, Pedro Ernesto University Hospital, State University of Rio de Janeiro, Rio de Janeiro, Brazil, uerj.br. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Actinic cheilitis (AC) is a common potentially malignant disorder that primarily affects the lower lip due to chronic ultraviolet B exposure. Severe epithelial dysplasia in AC carries a significant risk of progression to squamous cell carcinoma, necessitating definitive treatment. Vermilionectomy is considered the treatment of choice in high‐risk lesions, offering both functional and aesthetic restoration. This study reports the clinical outcomes of three cases of AC with severe dysplasia treated via vermilionectomy. Three patients (two males, one female) with a histopathologically confirmed diagnosis of AC exhibiting severe epithelial dysplasia underwent vermilionectomy under local anesthesia. Surgical management involved excision of the affected vermilion to the muscular plane, hemostasis with electrocautery, and advancement of labial mucosa for reconstruction, followed by suture closure with 4‐0 nylon. Postoperative recovery, complications, and aesthetic outcomes were assessed. All patients demonstrated complete healing without evidence of malignant transformation. Therefore, vermilionectomy is an effective and reliable treatment for AC with severe epithelial dysplasia, providing low recurrence rates and favorable functional and aesthetic outcomes. These cases reinforce the role of vermilionectomy as the definitive treatment for high‐risk AC lesions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Oral and Maxillofacial Surgery, Pedro Ernesto University Hospital, State University of Rio de Janeiro, Rio de Janeiro, Brazil, uerj.br.
- Department of Oral Medicine, Faculdade São Leopoldo Mandic, Rio de Janeiro, Brazil, slmandic.edu.br.
- Oral Medicine, Department of Diagnosis and Therapeutics, School of Dentistry, State University of Rio de Janeiro, Rio de Janeiro, Brazil, uerj.br.
ORCID-Profile: Bruno Teixeira Gonçalves Rodrigues, Eduardo Martins Falcão, Caroline Cavaignac Silva, Paula Granha Porto, Ana Carolina Silva Custódio, Allan Ribeiro Bastos, Verônica Dos Santos Lopes Serrano, Henrique Martins da Silveira, Danilo Passeado Branco Ribeiro, Mônica Simões Israel
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Rodrigues, B. T. G., Falcão, E. M., Silva, C. C., Porto, P. G., Custódio, A. C. S., Bastos, A. R., Dos Santos Lopes Serrano, V., da Silveira, H. M., Ribeiro, D. P. B., & Israel, M. S. (2026). Vermilionectomy for Actinic Cheilitis Treatment—Report of 03 Cases and Brief Literature Review. Case Reports in Dentistry, 2026(1). https://doi.org/10.1155/crid/9721944
Vancouver
Rodrigues BTG, Falcão EM, Silva CC, Porto PG, Custódio ACS, Bastos AR, et al. Vermilionectomy for Actinic Cheilitis Treatment—Report of 03 Cases and Brief Literature Review. Case Reports in Dentistry. 2026;2026(1). doi:10.1155/crid/9721944
BibTeX
@article{Rodrigues2026,
author = {Rodrigues, Bruno Teixeira Gonçalves and Falcão, Eduardo Martins and Silva, Caroline Cavaignac and Porto, Paula Granha and Custódio, Ana Carolina Silva and Bastos, Allan Ribeiro and Dos Santos Lopes Serrano, Verônica and da Silveira, Henrique Martins and Ribeiro, Danilo Passeado Branco and Israel, Mônica Simões},
title = {Vermilionectomy for Actinic Cheilitis Treatment—Report of 03 Cases and Brief Literature Review},
journal = {Case Reports in Dentistry},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/crid/9721944}
}
EUVIMED